Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Prostatic Neoplasms 8Leukemia 8Burkitt Lymphoma 7Recurrence 4Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, B-Cell 2Leukemia, Myeloid, Acute 2Rhabdoid Tumor 1Plasmablastic Lymphoma 1Pituitary Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Leukemia, T-Cell 1Leukemia, Mast-Cell 1Leukemia, Lymphoid 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

Mifepristone 3Corlux 3Thyrotropin-Releasing Hormone 1Hydrocortisone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pituitary Diseases × Hydrocortisone × Clear all
NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed
43 enrolled 8 charts
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡